The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTristel Share News (TSTL)

Share Price Information for Tristel (TSTL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 440.00
Bid: 430.00
Ask: 450.00
Change: 0.00 (0.00%)
Spread: 20.00 (4.651%)
Open: 440.00
High: 440.00
Low: 440.00
Prev. Close: 440.00
TSTL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director dealings: Tristel non-exec buys first shares, LSE buyback continues

Mon, 26th Jun 2023 11:07

(Sharecast News) - On the list of director buys on Monday was Tristel, after a non-executive director spent almost £30k on shares.

The infection prevention products manufacturer said that on 23 June, Tom Jenkins purchased 8,000 of its shares in a single transaction on the London Stock Exchange.

Jenkins paid 372p for each share, valuing the investment at a total of £29,760.

In its disclosure, Tristel said Jenkins' beneficial interest in the company now stood at 8,000 of its shares, representing 0.02% of its total issued share capital.

London Stock Exchange Group was once again representing the selling side of the ledger, as the buyback programme launched in the wake of its acquisition of Refinitiv rolled on.

The company said York Holdings II sold back another 12,071 of its shares, in a single transaction that also took place on 23 June.

It received 8,401.94p for each share, valuing the transaction at £1,014,198.18.

The exchange operator said in its disclosure that one of its directors, Martin Brand, is also a director of York Holdings II.

It is understood that York Holdings II is part of the structure of entities that holds the LSE Group shares that formed part of the consideration paid to Thomson Reuters and Blackstone on completion of its acquisition of Refinitiv.

A number of those shares exited lock-in restrictions earlier this year, leading to a share buyback agreement between LSE Group and the vendors of Refinitiv.

At 1439 BST, shares in London Stock Exchange Group were down 0.07% at 8,416p, while those in Tristel were 3.99% weaker at 364.84p.

Reporting by Josh White for Sharecast.com.

Top Director Buys

Oakley Capital Investments Ltd. (di) (OCI)

Director name: Till,David

Amount purchased: 50,000 @ 4,460.00p

Value: �2,229,999.92

Oakley Capital Investments Ltd. (di) (OCI)

Director name: Dubens,Peter

Amount purchased: 200,000 @ 446.00p

Value: �892,000.01

Lookers (LOOK)

Director name: Raban,Mark Douglas

Amount purchased: 93,709 @ 118.60p

Value: �111,138.87

Lookers (LOOK)

Director name: Laird,Oliver

Amount purchased: 58,307 @ 118.60p

Value: �69,152.10

Lookers (LOOK)

Director name: McPhee,Duncan

Amount purchased: 58,307 @ 118.60p

Value: �69,152.10

Tullow Oil (TLW)

Director name: Goethe,Roald

Amount purchased: 150,000 @ 29.69p

Value: �44,527.50

Tullow Oil (TLW)

Director name: Goethe,Roald

Amount purchased: 150,000 @ 29.48p

Value: �44,221.50

Tullow Oil (TLW)

Director name: Goethe,Roald

Amount purchased: 150,000 @ 28.98p

Value: �43,471.50

Tristel (TSTL)

Director name: Jenkins,Tom

Amount purchased: 8,000 @ 372.00p

Value: �29,760.00

Centralnic Group (CNIC)

Director name: Royde ,Max

Amount purchased: 18,000 @ 111.09p

Value: �19,996.02

European Assets Trust (EAT)

Director name: Troup,Kevin

Amount purchased: 20,000 @ 86.60p

Value: �17,319.40

Roquefort Therapeutics (ROQ)

Director name: West,Stephen Paul

Amount purchased: 144,117 @ 6.90p

Value: �9,944.07

European Assets Trust (EAT)

Director name: Breuer,Martin

Amount purchased: 6,700 @ 87.00p

Value: �5,829.00

Roquefort Therapeutics (ROQ)

Director name: Reginald,Trevor Ajanthan (Ajan)

Amount purchased: 35,265 @ 7.06p

Value: �2,489.71

Top Director Sells

London Stock Exchange Group (LSEG)

Director name: Brand,Martin

Amount sold: 12,071 @ 8,401.97p

Value: �1,014,201.79

More News
12 Oct 2015 09:47

Infection Control Firm Tristel Multiples Dividend As Profit Rises

Read more
12 Oct 2015 05:47

GET READY: Jupiter Fund Management At 0700 BST

Read more
5 Oct 2015 14:59

Earnings, Trading Statements Calendar - Week Ahead

Read more
18 Jun 2015 11:22

LONDON MIDDAY BRIEFING: Eyes Turn To Latest Greek Crisis Meeting

Read more
18 Jun 2015 10:38

WINNERS & LOSERS: Fresnillo, Randgold Resources Up As Gold Price Rises

Read more
18 Jun 2015 07:40

Tristel Shares Rise As It Reveals 3 Pence Special Dividend

Read more
21 May 2015 11:19

LONDON MIDDAY BRIEFING: Royal Mail Outlook Causes Concerns

Read more
21 May 2015 10:45

WINNERS & LOSERS: Miners Boosted By Chinese Stimulus Hopes

Read more
21 May 2015 07:39

Tristel Upgrades Profit Guidance As It Trades Ahead Of Expectations

Read more
25 Feb 2015 08:41

Tristel Raises Dividend 63% After Strong First-Half Profit Rise

Read more
11 Nov 2014 09:57

Tristel Says Another Study Has Shown Benefits Of Its Wipes Study

Read more
4 Nov 2014 15:16

Tristel chairman Soler trims stake

The chairman of hospital infection control experts Tristel sold a small chunk of his shares in the company late on Monday. Francisco Soler sold 250,000 shares in the dividend-paying company at a price of 75p per share on 31 October and on 3 November 2014 sold 100,000 more at the same price to gross

Read more
3 Nov 2014 18:08

DIRECTOR DEALINGS: Tristel Non-Executive Chairman Sells Shares

Read more
13 Oct 2014 14:46

Tristel boosts full-year profit after restructuring

Tristel, a manufacturer of infection prevention and contamination control products, saw profit for the year to end of June rise after undertaking a set of restructuring measures. An 18-month restructuring plan, the creation of new products and investment in the disinfection market led the firm to be

Read more
13 Oct 2014 09:23

Tristel Quadruples Dividend As It Swings To Profit On Restructuring

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.